Nashville, Tenn. – The Children’s Hospital at TriStar Centennial announced today that its Blood and Marrow Transplant (BMT) Program has received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). The designation affirms The Children’s Hospital’s adherence to stringent international standards for pediatric hematology and oncology care.
“Our transplant team has more than 25 years of combined experience performing more than 600 stem cell transplants. We strive to provide the highest level of pediatric hematology and oncology care for our patients by creating a worldrenowned blood and marrow transplant program founded on evidenced-based practices,” said Dr. Haydar Frangoul, pediatric hematologist and oncologist at The Children’s Hospital and Sarah Cannon Cancer Institute at TriStar Centennial. “We are honored to be part of a network made up of international experts vested in the improvement and progress of cellular therapy, and are able to provide the highest quality of care for pediatric patients right here in Nashville.”
The Children’s Hospital received FACT accreditation for autologous transplantation (utilizing a patient’s own stem cells) and allogenic transplantation (utilizing the cells of a matched donor), and immune effector cellular therapy, marrow and peripheral blood cellular therapy product collection and cellular therapy product processing with minimal manipulation.
Patients come to The Children’s Hospital for medical care in the pediatric stem cell transplant program from all over the southern region of the United States, including East Tennessee, Alabama, Arkansas and Mississippi.
“Our first autologous stem cell transplant was performed in June of 2015 followed by our first allogeneic stem cell transplant in September of 2015. We have since continued to experience significant growth in our pediatric hematology and oncology services,” said Joann Ettien, Chief Operating Officer at The Children’s Hospital. “Through the expertise and collaboration of our physicians, we provide a multidisciplinary approach to childhood cancer care and blood conditions. Our FACT accreditation underscores our commitment to parents to provide the highest level of care for pediatric stem cell transplant patients.”
Recently in September 2017, The Children’s Hospital opened its new pediatric hematology, oncology and stem cell transplant unit. The 20,000-square-foot and 11- bed department is a HEPA-filtered and positive pressure space, reducing the risk of infection and allowing children to explore outside of their room in the unit’s dedicated playroom and family area.